[Adrenomedullin: a new vasoactive peptide].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to A Cases.
Explore the source record for details and available documents.
In order to evaluate the specificity of tumor markers in chronic renal failure, we have determined serum levels of carcinoembryonic antigen (CEA), carbohydrate antigen 19.9 (CA 19.9), carbohydrate antigen 50 (CA 50), alphafetoprotein (AFP), neuron-specific enolase (NSE), prostatic acid phosphatase (PAP), prostatic specific antigen (PSA), squamous cell carcinoma antigen (SCC), carbohydrate antigen 15.3 (CA 15.3) and carbohydrate antigen 125 (CA 125) in 30 patients with chronic renal failure and in 36 hemodialyzed patients without clinical evidence of neoplasia. CEA, CA 50, NSE and SCC frequently show increased serum levels, suggesting a renal metabolism, while others remain, generally, within the normal levels.
A prospective study performed on 37 patients with end-stage renal disease who required treatment with deferoxamine is presented. Three patients presented a sudden sensorineural hearing loss, with tinnitus in one case, which was demonstrated to be of cochlear origin. All patients recovered auditory function completely after treatment was discontinued.
Explore the source record for details and available documents.